...
首页> 外文期刊>Biomedical Engineering, IEEE Transactions on >Effective Hydrodynamic Shaping of Sample Streams in a Microfluidic Parallel-Plate Flow-Assay Device: Matching Whole Blood Dynamic Viscosity
【24h】

Effective Hydrodynamic Shaping of Sample Streams in a Microfluidic Parallel-Plate Flow-Assay Device: Matching Whole Blood Dynamic Viscosity

机译:在微流平行板流动测定装置中有效地对样品流进行流体动力学成形:匹配全血动态粘度

获取原文
获取原文并翻译 | 示例

摘要

We report the development of an aqueous buffer system tailored to the fluidic and hemodynamic requirements of our recently reported microfluidic platelet dynamic assay device, which uses hydrodynamic focusing to “shape” a blood sample into a thin flowing layer adjacent to its protein-functionalized surface. By matching the dynamic viscosity of whole blood (3.13 ± 0.08 mPa·s, from healthy donors), the selected buffer minimizes interfacial fluid mixing and better controls shear rate within the device, permitting platelet/protein-surface interaction assays with as little as 50 μL of whole blood. Buffers containing the viscosity-enhancing components bovine serum albumin (BSA), gelofusine/glycine, or histopaque (Ficoll gradient solution) were found not to activate platelets when incubated with blood at concentrations up to 50%, as assessed by flow cytometry quantitation of P-selectin expression and αIIbβ $_3$ activation. In contrast, glycerol-based buffer activated platelets (two-fold increase in P-selectin levels) at concentrations as low as 10% by volume. BSA- and gelofusine/glycine-based buffers were problematic in preparation and use, and therefore, were not used beyond initial characterization. The histopaque solution selected as the best choice for flow studies stabilizes sample contact with the device''s thrombogenic surface, does not activate platelets, and does not interfere with the action of agonists added to deliberately activate platelets.
机译:我们报告了根据我们最近报道的微流体血小板动态测定装置的流体和血液动力学要求量身定制的水性缓冲系统的开发,该装置使用流体动力学聚焦将血液样本“成形”为与蛋白质功能化表面相邻的薄流动层。通过匹配全血的动态粘度(3.13±0.08 mPa·s,来自健康供体),选择的缓冲液可最大程度地减少界面液的混合并更好地控制设备内的剪切速率,从而使血小板/蛋白质-表面相互作用的测定量低至50微升全血。通过流式细胞术定量P评估,当与浓度高达50%的血液孵育时,发现含有增粘成分牛血清白蛋白(BSA),明胶碱/甘氨酸或组蛋白(Ficoll梯度溶液)的缓冲液不会激活血小板。 -选择素表达和αIIbβ$ _3 $激活。相反,基于甘油的缓冲液激活的血小板(P-选择素水平增加了两倍)的浓度低至10%(体积)。基于BSA的和基于品红霉素/甘氨酸的缓冲液在制备和使用中存在问题,因此,除最初表征外,没有使用。被选作流动研究最佳选择的组蛋白溶液可稳定样品与装置的血栓形成表面的接触,不会激活血小板,也不会干扰故意激活血小板的激动剂的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号